Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia
Blood
.
2023 Feb 23;141(8):951-955.
doi: 10.1182/blood.2022018051.
Authors
Graça M Dores
1
,
Martha S Linet
1
,
Rochelle E Curtis
1
,
Lindsay M Morton
1
Affiliation
1
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD.
PMID:
36379026
PMCID:
PMC10082352
DOI:
10.1182/blood.2022018051
No abstract available
MeSH terms
Hematologic Neoplasms*
Humans
Leukemia, Myeloid, Acute*
Myelodysplastic Syndromes*
Neoplasms, Second Primary*